PGHL

Procter & Gamble Health Share Price

₹5,195.00 -49 (-0.93%)

19 May, 2025 00:05

SIP TrendupStart SIP in PGHL

Start SIP

Performance

  • Low
  • ₹5,171
  • High
  • ₹5,261
  • 52 Week Low
  • ₹4,641
  • 52 Week High
  • ₹5,850
  • Open Price₹5,253
  • Previous Close₹5,244
  • Volume5,034

Investment Returns

  • Over 1 Month -0.44%
  • Over 3 Month -2.02%
  • Over 6 Month + 0.91%
  • Over 1 Year + 8.4%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.5
  • PEG Ratio
  • 8.3
  • Market Cap Cr
  • 8,623
  • P/B Ratio
  • 13.9
  • Average True Range
  • 114.94
  • EPS
  • 147.87
  • Dividend Yield
  • 2.7
  • MACD Signal
  • -32.26
  • RSI
  • 54
  • MFI
  • 36.57

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,195.00
-49 (-0.93%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹5,136.51
  • 50 Day
  • ₹5,180.52
  • 100 Day
  • ₹5,219.15
  • 200 Day
  • ₹5,212.50

Resistance and Support

5208.67 Pivot Speed
  • R3 5,336.83
  • R2 5,298.67
  • R1 5,246.83
  • S1 5,156.83
  • S2 5,118.67
  • S3 5,066.83

What's your outlook on Procter & Gamble Health?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide.

Procter & Gamble Health has an operating revenue of Rs. 1,159.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 1% and -0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-29 Audited Results & Final Dividend
2025-02-12 Quarterly Results & Interim Dividend
2024-11-04 Quarterly Results
2024-08-21 Audited Results & Final Dividend
2024-05-02 Quarterly Results
Date Purpose Remarks
2025-02-21 INTERIM Rs.80.00 per share(800%)Interim Dividend
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend
View More

Procter & Gamble Health F&O

Procter & Gamble Health Shareholding Pattern

51.82%
10.54%
3.47%
6.86%
0%
21.9%
5.41%

About Procter & Gamble Health

  • NSE Symbol
  • PGHL
  • BSE Symbol
  • 500126
  • Managing Director
  • Mr. Milind Thatte
  • ISIN
  • INE199A01012

Similar Stocks to Procter & Gamble Health

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,195 As on 18 May, 2025 | 23:51

The Market Cap of Procter & Gamble Health is ₹8623.4 Cr As on 18 May, 2025 | 23:51

The P/E ratio of Procter & Gamble Health is 36.5 As on 18 May, 2025 | 23:51

The PB ratio of Procter & Gamble Health is 13.9 As on 18 May, 2025 | 23:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23